These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12774329)

  • 21. Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain.
    Gagnaire F; Chalansonnet M; Carabin N; Micillino JC
    Arch Toxicol; 2006 Oct; 80(10):703-12. PubMed ID: 16518643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preliminary experimental study on therapeutic mechanism of kangzhen zhijing capsule in treating Parkinson's disease].
    Bao YC; Wang H; Zhang B
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Mar; 21(3):193-5. PubMed ID: 12577336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapeutic effects of traditional Chinese herbal formula with Smilax glabra on mice's lead poisoning].
    Xia DZ; Wang HM; Yang Q; Jiang LQ; Xia M
    Zhong Yao Cai; 2009 Mar; 32(3):404-6. PubMed ID: 19565723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidepressant evaluation of polysaccharides from a Chinese herbal medicine Banxia-houpu decoction.
    Guo Y; Kong L; Wang Y; Huang Z
    Phytother Res; 2004 Mar; 18(3):204-7. PubMed ID: 15103666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of acupuncture and Chinese medicine treatment on brain dopamine level of MPTP-lesioned C57BL mice].
    Zhu W; Xi G; Ju J
    Zhen Ci Yan Jiu; 1996; 21(4):46-9. PubMed ID: 9388318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
    Srinivasan J; Schmidt WJ
    Behav Brain Res; 2004 May; 151(1-2):191-9. PubMed ID: 15084435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
    Leng A; Mura A; Hengerer B; Feldon J; Ferger B
    Behav Brain Res; 2004 Oct; 154(2):375-83. PubMed ID: 15313025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective alterations of gene expression in mice induced by MPTP.
    Xu Z; Cawthon D; McCastlain KA; Slikker W; Ali SF
    Synapse; 2005 Jan; 55(1):45-51. PubMed ID: 15499605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic profile of talipexole in healthy volunteers is not altered when it is co-administered with Madopar (co-beneldopa).
    Zhang TT; Song M; Hang TJ; Xu XF; Wen AD; Yang L; Jia L
    J Clin Pharm Ther; 2009 Jun; 34(3):345-54. PubMed ID: 19646081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease.
    Meuer K; Pitzer C; Teismann P; Krüger C; Göricke B; Laage R; Lingor P; Peters K; Schlachetzki JC; Kobayashi K; Dietz GP; Weber D; Ferger B; Schäbitz WR; Bach A; Schulz JB; Bähr M; Schneider A; Weishaupt JH
    J Neurochem; 2006 May; 97(3):675-86. PubMed ID: 16573658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time-dependent effects of levodopa on regional brain dopamine metabolism and lipid peroxidation.
    Loeffler DA; LeWitt PA; Juneau PL; Camp DM; Arnold LA; Hyland K
    Brain Res Bull; 1998 Dec; 47(6):663-7. PubMed ID: 10078623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study of brain dopamine sulfate levels in relation to free dopamine and homovanillic acid in Parkinson's disease.
    Sofic E; Riederer P; Wesemann W; Kienzl E; Eichinger K; Gsell W; Jellinger K
    J Neural Transm Park Dis Dement Sect; 1991; 3(4):265-71. PubMed ID: 1772579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study of the effect of exceed critical extracts from Radix Aucklandiae on experimental gastric ulcer model].
    Han J; Lin H; Zhong Z; Rong X
    Zhong Yao Cai; 2005 Nov; 28(11):1017-9. PubMed ID: 16514893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of Guanyu capsule on the behavior and cerebral cortex monoamine neurotransmitters in depressive model of olfactory bulb damage rats].
    Wang JX; Zhang JJ; Zhong GS; Zhang DQ; Hu SM; Li W; Ou LN; Gao XM
    Zhongguo Zhong Yao Za Zhi; 2005 May; 30(10):782-5. PubMed ID: 16075721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paraquat induces selective dopaminergic nigrostriatal degeneration in aging C57BL/6 mice.
    Li X; Yin J; Cheng CM; Sun JL; Li Z; Wu YL
    Chin Med J (Engl); 2005 Aug; 118(16):1357-61. PubMed ID: 16157030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transplantation of autologous sympathetic neurons as a potential strategy to restore metabolic functions of the damaged nigrostriatal dopamine nerve terminals in Parkinson's disease.
    Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
    Brain Res Rev; 2006 Sep; 52(2):244-56. PubMed ID: 16644019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotective effect of arundic acid, an astrocyte-modulating agent, in mouse brain against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity.
    Himeda T; Kadoguchi N; Kamiyama Y; Kato H; Maegawa H; Araki T
    Neuropharmacology; 2006 Mar; 50(3):329-44. PubMed ID: 16303147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats.
    Rojo AI; Cavada C; de Sagarra MR; Cuadrado A
    Exp Neurol; 2007 Nov; 208(1):120-6. PubMed ID: 17880941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A simple rodent assay for the in vivo identification of agents with potential to reduce levodopa-induced dyskinesia in Parkinson's disease.
    Johnston TH; Lee J; Gomez-Ramirez J; Fox SH; Brotchie JM
    Exp Neurol; 2005 Feb; 191(2):243-50. PubMed ID: 15649479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor.
    Dhir A; Kulkarni SK
    Eur J Pharmacol; 2007 Jul; 568(1-3):177-85. PubMed ID: 17509558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.